An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
Status:
Completed
Trial end date:
2019-08-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of Losartan potassium in
subjects with eosinophilic esophagitis (EoE) including those with a connective tissue
disorder (CTD) and those without a CTD.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
National Center for Advancing Translational Science (NCATS) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Office of Rare Diseases (ORD)